Biovie logo

Biovie Share Price (NASDAQ: BIVI)

$1.61

0.03

(1.9%)

Last updated on

Check the interactive Biovie Stock chart to analyse performance

Biovie stock performance

as on August 28, 2025 at 11:36 pm IST

  • Today's Low:$1.60
    Today's High:$1.64

    Day's Volatility :2.74%

  • 52 Weeks Low:$1.46
    52 Weeks High:$75.00

    52 Weeks Volatility :98.05%

Biovie Stock Returns

PeriodBiovie IncSector (Health Care)Index (Russel 2000)
3 Months
-84.72%
4.2%
0.0%
6 Months
-87.73%
-8.0%
0.0%
1 Year
-94.09%
-12.1%
0.0%
3 Years
-99.5%
7.6%
-6.9%

Biovie Inc Key Stats

Check Biovie key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.62
Open
$1.595
Today's High
$1.56
Today's Low
$1.5
Market Capitalization
$11.9M
Today's Volume
$159.9K
52 Week High
$75.0
52 Week Low
$1.46
Revenue TTM
$0.0
EBITDA
$-17.8M
Earnings Per Share (EPS)
$-12.12
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-101.64%

Stock Returns calculator for Biovie Stock including INR - Dollar returns

The Biovie stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Biovie investment value today

Current value as on today

₹10,236

Returns

₹89,764

(-89.76%)

Returns from Biovie Stock

₹94,124 (-94.12%)

Dollar Returns*

₹4,360 (+4.36%)

Indian investors sentiment towards Biovie Stock

104%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Biovie Stock from India on INDmoney has increased by 104% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Biovie Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    2.89%

  • Geode Capital Management, LLC

    0.74%

  • Goss Wealth Management LLC

    0.29%

  • UBS Group AG

    0.27%

  • SMH Capital Inc.

    0.22%

  • HPM Partners LLC

    0.16%

Analyst Recommendation on Biovie Stock

Rating
Trend

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Biovie(by analysts ranked 0 to 5 stars)

Biovie Share Price Target

What analysts predicted

Upside of 3626.71%

Target:

$60.00

Current:

$1.61

Biovie share price target is $60.00, a slight Upside of 3626.71% compared to current price of $1.61 as per analysts' prediction.

Biovie Stock Insights

  • Price Movement

    In the last 1 month, BIVI stock has moved down by -77.2%
  • BIVI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.8% return, outperforming this stock by 155.9%
  • BIVI vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 115.3% return, outperforming this stock by 214.7%

Biovie Technicals Summary

Sell

Neutral

Buy

Biovie is currently in a neutral trading position according to technical analysis indicators.

Biovie Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Biovie Inc logo
-76.74%
-87.73%
-94.09%
-99.5%
-99.84%
Regeneron Pharmaceuticals, Inc. logo
5.16%
-16.48%
-51.06%
-0.98%
-5.32%
Beone Medicines Ltd logo
-1.83%
7.82%
51.46%
79.4%
24.25%
Vertex Pharmaceuticals Incorporated logo
-16.94%
-18.0%
-20.55%
38.17%
39.4%
Alnylam Pharmaceuticals, Inc. logo
37.4%
91.56%
61.8%
117.28%
242.42%

About Biovie Inc

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
Organization
Biovie
Employees
13
CEO
Mr. Cuong Viet Do M.B.A.
Industry
Biotechnology

Key Management of Biovie Inc

NameTitle
Mr. Cuong Viet Do M.B.A.
President, CEO & Director
Dr. Joseph M. Palumbo M.D.
Executive VP of R&D and Chief Medical Officer
Mr. Clarence N. Ahlem
Senior Vice President of Operations
Dr. Penelope Markham Ph.D.
Senior Vice President of Liver Disease Program
Ms. Denise Smith
Senior Vice President of Manufacturing & Development
Dr. Christopher L. Reading Ph.D.
Senior Vice President of Alzheimer's Disease Program
Mr. David Morse
Senior VP & Chief Regulatory Officer

Important FAQs about investing in BIVI Stock from India :

What is Biovie share price today?

Biovie share price today is $1.61 as on at the close of the market. Biovie share today touched a day high of $1.64 and a low of $1.60.

What is the 52 week high and 52 week low for Biovie share?

Biovie share touched a 52 week high of $75.00 and a 52 week low of $1.46. Biovie stock price today i.e. is closed at $1.61, lower by 97.85% versus the 52 week high.

How to invest in Biovie Stock (BIVI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biovie on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biovie Shares that will get you 0.9317 shares as per Biovie share price of $1.61 per share as on August 28, 2025 at 11:36 pm IST.

What is the minimum amount required to buy Biovie Stock (BIVI) from India?

Indian investors can start investing in Biovie (BIVI) shares with as little as ₹87.587 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.87 in Biovie stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Biovie share’s latest price of $1.61 as on August 28, 2025 at 11:36 pm IST, you will get 6.2112 shares of Biovie. Learn more about fractional shares .

What are the returns that Biovie has given to Indian investors in the last 5 years?

Biovie stock has given -99.84% share price returns and 18.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?